Xiaojuan Du

427 total citations
16 papers, 314 citations indexed

About

Xiaojuan Du is a scholar working on Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiaojuan Du has authored 16 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiaojuan Du's work include Liver Disease Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (4 papers) and Lipid metabolism and disorders (3 papers). Xiaojuan Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (4 papers) and Lipid metabolism and disorders (3 papers). Xiaojuan Du collaborates with scholars based in China, United States and Sweden. Xiaojuan Du's co-authors include Litao Wu, Dongmin Li, Kaikai Lu, Shemin Lu, Xi Lan, Farooq Riaz, Xudong Yang, Xiaofei Yan, Qian Chen and Fujun Zhang and has published in prestigious journals such as Toxicology and Applied Pharmacology, Molecular and Cellular Endocrinology and BMC Cancer.

In The Last Decade

Xiaojuan Du

15 papers receiving 309 citations

Peers

Xiaojuan Du
Lili Zhuo China
Hu Zhang China
Jonathan C. Jaoude United States
Henglei Lu China
Petra Thulin Sweden
Xinrui Cai China
Małgorzata Guz Poland
Mosang Yu China
Lili Zhuo China
Xiaojuan Du
Citations per year, relative to Xiaojuan Du Xiaojuan Du (= 1×) peers Lili Zhuo

Countries citing papers authored by Xiaojuan Du

Since Specialization
Citations

This map shows the geographic impact of Xiaojuan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Du more than expected).

Fields of papers citing papers by Xiaojuan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojuan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Du. The network helps show where Xiaojuan Du may publish in the future.

Co-authorship network of co-authors of Xiaojuan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojuan Du. A scholar is included among the top collaborators of Xiaojuan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojuan Du. Xiaojuan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Du, Xiaojuan, Yong Tao, Yuqian Wu, et al.. (2024). Progress in the mechanism of functional dyspepsia: roles of mitochondrial autophagy in duodenal abnormalities. Frontiers in Medicine. 11. 1491009–1491009.
2.
Lan, Xi, Jiajun Ren, Xiaojuan Du, et al.. (2023). lnc-HC ameliorates steatosis by promoting miR-130b-3p biogenesis and the assembly of an RNA-induced silencing complex. Molecular and Cellular Endocrinology. 578. 112061–112061. 4 indexed citations
3.
Du, Xiaojuan, Qian Chen, Xiaofei Yan, et al.. (2022). Pdcd4 promotes lipid deposition by attenuating PPARα-mediated fatty acid oxidation in hepatocytes. Molecular and Cellular Endocrinology. 545. 111562–111562. 12 indexed citations
4.
Chen, Yanping, Ke Xu, Yingchao Li, et al.. (2022). Cholesterol-induced leucine aminopeptidase 3 (LAP3) upregulation inhibits cell autophagy in pathogenesis of NAFLD. Aging. 14(7). 3259–3275. 15 indexed citations
5.
Li, Jing, Qian Chen, Jing Yi, et al.. (2021). IFN-γ contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1β/TLR2 signaling pathway. Molecular Immunology. 134. 118–128. 19 indexed citations
6.
Du, Xiaojuan, Xi Lan, Farooq Riaz, et al.. (2021). Induction of PDCD4 by albumin in proximal tubule epithelial cells potentiates proteinuria-induced dysfunctional autophagy by negatively targeting Atg5. Biochemistry and Cell Biology. 99(5). 617–628. 2 indexed citations
7.
Riaz, Farooq, Qian Chen, Kaikai Lu, et al.. (2021). Inhibition of miR‐188‐5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. Journal of Cellular and Molecular Medicine. 25(8). 4073–4087. 39 indexed citations
8.
Wu, Litao, Li Liu, Xiaojuan Du, et al.. (2020). Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways. International Immunopharmacology. 82. 106368–106368. 20 indexed citations
9.
Tan, Shuai, Xi Lan, Wenhua Zhu, et al.. (2020). Effects and Mechanisms of Autophagy Induced by Solubilized-Cholesterol in Hepatocytes: A Comparative Study Among Solvents. Cell Biochemistry and Biophysics. 78(3). 357–366. 1 indexed citations
10.
Lan, Xi, Nan Wu, Litao Wu, et al.. (2020). The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p. Molecular Therapy — Nucleic Acids. 20. 468–479. 22 indexed citations
11.
12.
Wu, Litao, Xiaojuan Du, Fujun Zhang, et al.. (2019). Anti-Toll-like receptor 2 antibody inhibits nuclear factor kappa B activation and attenuates cardiac damage in high-fat-feeding rats. Acta Biochimica et Biophysica Sinica. 51(4). 347–355. 8 indexed citations
13.
Lan, Xi, Litao Wu, Nan Wu, et al.. (2019). Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p. Molecular Therapy — Nucleic Acids. 18. 954–965. 47 indexed citations
14.
Yan, Xiaofei, Meng Xun, Litao Wu, et al.. (2018). DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na + -K + -ATPase, inhibiting Na + -K + -ATPase/ROS pathway and activating PI3K/Akt and ERK1/2. Toxicology and Applied Pharmacology. 349. 62–71. 9 indexed citations
15.
Wang, Xuan, Meichen Wang, Hongmin Li, et al.. (2015). Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor. Molecular and Cellular Endocrinology. 416. 57–69. 24 indexed citations
16.
Tao, Yanfang, Jun Lu, Xiaojuan Du, et al.. (2012). Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer. 12(1). 619–619. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Zhuo Breakdown of academic impact, for papers by Hu Zhang Breakdown of academic impact, for papers by Jonathan C. Jaoude Breakdown of academic impact, for papers by Henglei Lu Breakdown of academic impact, for papers by Petra Thulin Breakdown of academic impact, for papers by Xinrui Cai Breakdown of academic impact, for papers by Małgorzata Guz Breakdown of academic impact, for papers by Mosang Yu
Rankless by CCL
2026